CClinicalTrials.gg
Not yet recruitingNCT07108218Updated Aug 6, 2025

Lateral Positioning for Extubation After Adenotonsillectomy

An interventional study of lateral postion and supine position in Perioperative Respiratory Adverse Events, Adenoidectomy and Tonsillectomy, sponsored by Sichuan University. Not yet recruiting at 1 site in China. Open to participants aged 1 Year to 6 Years. Per ClinicalTrials.gov, last updated 2025-08-06.

Sponsored by Sichuan University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
350
Allocation
Randomized
Ages
1 Year to 6 Years
Sex
All
01

Study summary

The postoperative recovery period following general anesthesia has been associated with a 30%-50% incidence of postoperative respiratory adverse events (PRAEs) in pediatric populations, including laryngospasm, airway obstruction, and hypoxemia. Despite the limited effects of existing pharmacological and operative interventions, positional optimization (e.g., lateral or semirecumbent position) may play a potential role by decreasing airway resistance and improving oxygenation. However, evidence-based evidence for its use in pediatric populations is still lacking, necessitating the urgent need for randomized controlled trials.

Read the detailed description

This study is a multi-center, prospective, RCT conducted at four tertiary hospitals in China. It will be planned to include 350 subjects who meet the inclusion criteria and will be randomly divided into the lateral position and supine position group in a 1:1 ratio by the method of block group randomization stratified by centers. In the supine position group, the children will be extubated at the end of the procedure and observed in the decubitus position until the patient's Aldrete score was >9 and they left the PACU, whereas in the lateral position group, the children will be extubated and observed in the head-up 30° lateral position. The primary outcome is the incidence of PRAEs. Secondary outcomes included frequency of PRAE, number of airway devices used during the postoperative recovery period, time to tracheal extubation, length of stay in the recovery room, and incidence of PRAE at 24 hours and 7 days. postoperatively. Safety outcomes include the incidence of peripheral IV access dislodgement, monitoring device detachment rate, and patient falls rate. Exploratory outcomes comprise pain levels (assessed via the FLACC scale), agitation scores (PAED scale), sedation scores (Ramsay scale), and PONV scores, all evaluated at postoperative extubation and PACU discharge.

02

Conditions studied

  • Perioperative Respiratory Adverse Events
  • Adenoidectomy
  • Tonsillectomy
  • Children
03

In context

Lead sponsor

Sichuan University is the lead sponsor of 106 studies on the registry; 65 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Year to 6 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Subjects aged 1-6 years old without gender limit.
  2. Scheduled for an ambulatory adenotonsillectomy under general anesthesia.
  3. American Society of Anesthesiologists (ASA) classification grade I or II.
  4. Informed consent obtained from the patients' parents or legal guardians, who have expressed willingness to cooperate.

Exclusion criteria

Exclusion criteria:

  1. Presence of concomitant cardiac or pulmonary dysfunction or other significant systemic comorbidities.
  2. History of difficult airway management or congenital/acquired structural anomalies of the airway.
  3. Active respiratory tract infection within 30 days preceding surgery.
  4. Preoperative neurological disorders or developmental abnormalities.
  5. Intraoperative occurrence of major complications necessitating deviation from the planned anesthesia protocol or surgical procedure.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
350 participants (estimated)

Study arms

  • Experimental
    lateral position group

    In the experimental group, the children will be placed in a head-up 30° lateral position for tracheal extubation and observation at the end of the procedure.

    Procedure: lateral postion

  • Placebo comparator
    the supine position group

    In the control group, the patients will be placed into a supine position for extubation and observation at the end of the procedure.

    Procedure: supine position

Interventions

  • Procedurelateral postion

    The children will be positioned on their sides with their heads elevated by 30°, a thin pillow behind their backs, the upper legs bent, and the lower legs straightened.

  • Proceduresupine position

    The children will be changed to a supine flat-lying position for extubation.

06

What researchers measure

Primary outcomes

  1. the occurrence of postoperative respiratory adverse events (PRAEs)

    PRAEs include a diverse array of respiratory complications, including laryngospasm, bronchospasm, apnea, airway obstruction, stridor, cough/choking, hypoxemia.

    Time frame: during PACU

Secondary outcomes

  1. Frequency of PRAEs

    Frequency of PRAEs: Record the category and count of each PRAE occurring in each child.

    Time frame: during PACU

  2. Number of Emergency Airway Interventions

    Number of Emergency Airway Interventions: including verbal stimulation, abdominal comparession, jaw thrust, mask ventilation, rescue intubation, etc

    Time frame: during PACU

  3. Tracheal extubation time

    Tracheal extubation time: From the time the patient is transferred to the PACU until the intubation is removed. Extubation criteria: spontaneous breathing recovery and spontaneous eye opening.

    Time frame: during PACU

  4. PACU stay duration

    PACU stay duration: time from PACU admission until meeting PACU discharge criteria(\*Aldrete score ≥9/10)

    Time frame: during PACU

  5. Length of hospital stay

    Length of hospital stay

    Time frame: postoperative day 1

  6. The PRAEs at 24 hours after surgery

    The PRAEs at 24 hours after surgery include laryngospasm, bronchospasm, airway obstruction, stridor, cough/choking, hypoxemia, upper respiratory tract infection and pulmonary infection.

    Time frame: at 24 hours postoperatively

  7. The PRAEs at 7 days after surgery

    The PRAEs at 7 days postoperatively include laryngospasm, bronchospasm, airway obstruction, stridor, cough/choking, hypoxemia, upper respiratory tract infection and pulmonary infection.

    Time frame: at 7 days postoperatively

Other outcomes

  1. Adverse events

    Adverse events include the incidence of peripheral intravenous access dislodgment, monitoring device detachment rate, and the rate of bed falls. Other adverse events including hypertension, hypotension, tachycardia, bradycardia, arrhythmias are also recorded.

    Time frame: during PACU

  2. Pain score

    Pain levels are evaluated using the FLACC scale. The scale has 5 categories (face, legs, activity, cry, consolability). Each category is scored on the 0-2 scale, which results in a total score of 0-10 (0=relaxed and comfortable; 1-3=mild discomfort; 4-6 = moderate pain; 7-10 = sever discomfort or pain or both).

    Time frame: every 10 minutes after extubation, when leaving the PACU.

  3. Emergence agitation

    Emergence agitation are evaluated using the PAED scale defined as a score ≥10.

    Time frame: every 10 minutes after extubation, when leaving the PACU.

  4. Sedation scores

    Sedation scores are evaluated using the Ramsay scale. The Ramsay sedation score with scores of 1(irritability), 2(consciousness and cooperative), 3(deeper sleep and more agile response), 4(lighter sleep with faster awakening time), 5(sound sleep with slow response), and 6(no response) points, respectively.

    Time frame: every 10 minutes after extubation, when leaving the PACU.

  5. Postoperative nausea and vomiting (PONV)

    The assessment of postoperative nausea and vomiting (PONV) involves observing and inquiring about the presence of nausea, vomiting, or retching in the child.

    Time frame: every 10 minutes after extubation, when leaving the PACU.

07

Study locations

1 site
  • West China Hospital
    Chengdu, Sichuan 610041, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07108218
Lead sponsor
Sichuan University
Responsible party
Peng Liang,MD (Professor, Sichuan University) — Principal investigator
First posted
Aug 6, 2025
Start date
Aug 20, 2025 (estimated)
Primary completion
Aug 20, 2026 (estimated)
Completion
Aug 27, 2026 (estimated)
Last update
Aug 6, 2025

Study contacts

Peng Liang, PhD
Contact
liangpengwch@scu.edu.cn
18980602201
Peng Liang, PhD
study director · West China Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion